Youth with congenital deafness treated with gene therapy showed better progress on certain hearing measures than counterparts ...

In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be ...

Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System – the world’s first and only, ...

Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware ...

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ Nucleus® Nexa™ System ...

The Nucleus Nexa System builds upon Cochlear's industry-leading portfolio of electrodes, which are designed to optimize the electrode-neural interface and protect cochlear health for a lifetime of ...

BOAO, China, June 20, 2025 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System – the world's first and only ...

If you're looking to invest $5,000 in ASX shares with a long-term growth mindset, there are plenty of quality companies to choose from. Cochlear could be an ASX share to buy and hold for growth ...

This column introduces PIVOTBY, a new Excel function that may let you say bye-bye to PivotTables.

Two Tucson patients participated in a clinical trial to receive Acclaim, the nation’s first fully implanted cochlear implant that functions without any external equipment.

A clinical trial on the VIA Disc NP treatment for discogenic back pain has shown impressive results, significantly reducing pain and improving back function. The non-surgical, minimally invasive ...